期刊文献+

GLP体系下生化分析仪的3Q验证过程及要点 被引量:8

Procedures and main points of 3Q validation for biochemical analyzers under the GLP system
原文传递
导出
摘要 目的以日立7100型全自动生化仪为例,探讨良好实验室规范(GLP)管理体系下生化分析仪的3Q验证过程及要点。方法根据美国临床和实验室标准研究所(CLSI)的评价标准,选择血清丙氨酸转氨酶(ALT)、天门冬氨酸转氨酶(AST)、碱性磷酸酶(ALP)、γ-谷氨酰基转肽酶(GGT)、总蛋白(TP)、白蛋白(Alb)、总胆红素(TB)、总胆固醇(CHOL)、甘油三酯(TG)、血糖(Glu)、肌酸激酶(CK)、肌酐(Cre)、尿素(Urea)等13项生化检验指标,对仪器的精密度、准确度、线性、携带污染率以及仪器对比实验进行性能验证。结果所测13项指标的批内精密度CV值≤3%,均小于美国临床和实验室修正法规1988(CLIA'88)最大总误差的1/4;批间CV值均小于CLIA'88最大总误差的1/3;在准确度方面,与靶值的相对偏差,除肌酐为8%外,其余12项均在±5%以内,且符合CLIA'88的要求;13项线性实验相关系数r>0.99,携带污染率<2.5%;对比实验结果显示,7100型生化仪与RA1000型生化仪各项的相关系数r>0.975,有较好的相关性。结论经GLP体系下的3Q验证,该型全自动生化分析仪各方面性能良好,可以用于临床检验实验室的检测工作。 Objective To explore the procedures and main points of the installation,operation and performance qualifi- cations (3Q) validation for biochemical analyzers under the Good Laboratory Practice (GLP) management system based on the Hitachi 7100 automatic biochemical analyzer. Methods According to the evaluation criteria of Clinical and Laboratory Standards Institute (CLSI),thirteen biochemical items were chosen to evaluate the precision, accuracy; linearity, cross contamination, and machine comparison of the 7100 automatic biochemical analyzer. They were alanine aminotransferase ( ALT), aspartate aminotransferase ( AST), alkaline phosphatase ( ALP), gamma-glutamyl transpeptidase ( GGT), total protein ( TP), albumin (Alb), total bilirubin ( TB), total cholesterol ( CHOL), triglycerides ( TG), glucose ( Glu ), crea tine kinase( CK), creatinine(Cre) ,and urea,respectively. Results The within-run precision( CV≤3% ) of thirteen items was one-fourth lower than that of Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA' 88 ) and the between-run precision was one-third lower than that of CLIA' 88. The relative biases for accuracy of the twelve items were in the range of 5% except creatinine (8%). The linear coefficient r of thirteen items was more than 0.99. The cross contamination rate of the thirteen items was less than 2.5%. The comparison experiment between Hitachi 7100 and RA1000 biochemical analyzers showed the result was good, with a coefficient of more than 0. 975. Conclusion The 3Q validation under the GLP system proves that the Hitachi 7100 automatic biochemical analyzer is good in performance and is appropriate for clinical laboratories.
出处 《军事医学》 CAS CSCD 北大核心 2013年第10期752-755,共4页 Military Medical Sciences
基金 国家科技重大专项资助项目(2009ZX09501-034)
关键词 良好实验室规范 生化分析仪 实验室技术和方法 3Q验证 精密度 准确度 good laboratory practice biochemical analyzer laboratory techniques and procedures 3Q validation preci-sion accuracy
  • 相关文献

参考文献7

  • 1FDA. 21 CFR Part 58: Good laboratory practice regulations final rule [EB/OL]. Rockville, Md,USA: U. S. FDA, 1987. http:// www. fda. gov/ora/compliance_ref/bimo/glp/87fr-glpamendment. pdf.
  • 2OECD . The OECD principles of good laboratory practice [ EB/ OL ]. Paris : OECD, 1998. http ://www. sourceoecd, org/ 9264012826. html.
  • 3国家食品药品监督管理局.药物非临床研究质量管理规范[EB/OL].北京:SFDA, 2003. http://www, sda. gov. cn/WSO1/CL0053/24472. html.
  • 4Bansal SK, Layloff T, Bush ED, et al. Qualification of analytical instruments for use in the pharmaceutical industry: a scientific approach[J]. AAPS Pharm Sci Tech, 2004, 5 (1) : E22.
  • 5Clinical and Laboratory Standards Institute ( CLSI ). Evaluation of precision performance of quantitative measurement methods: approved guideline-second edition. Document EPS-A[ S]. 2004.
  • 6Clinical and Laboratory Standards Institute (CLSI). Evaluation of the linearity of quantitative measurement procedures: a statistical approach;approved guideline. Document EP6-A[S]. 2003.
  • 7Clinical and Laboratory Standards Institute (CLSI). Method com- parison and bias estimation using patient samples; approved guide- line. DocumenEP9-A2 [ S ]. 2002.

同被引文献85

  • 1于文莲,陈会明,宋乃宁,程艳,周丽丽,王立峰,王,孙鑫.良好实验室规范与实验室认证[J].分析试验室,2010,29(5):120-122. 被引量:14
  • 2杨琛懋,马璟.关于GLP实验室仪器验证的探讨[J].毒理学杂志,2007,21(4):285-285. 被引量:10
  • 3孟建华,谢寅,王秀文,李波.GLP实验室SOP的控制与管理[J].中国药事,2007,21(9):689-691. 被引量:16
  • 4霍艳,谢寅,汪巨峰.GLP组织机构和管理体系的建立与运行[J].中国药理学与毒理学杂志,2013,27(3):458.
  • 5ISO/IEC 17025. General requirements for the competence of testing and calibration laboratories (ISO/IEC 17025 [S]. 2005.
  • 6Burgess C, McDowall RD. An integrated risk assessment for analytical instruments and computerized laboratory sys- tems [J]. Spctroscopy, 2013,28 (11 ) : 20-27.
  • 7U.S. FDA. Code of Federal Regulations: 21 CFR 211-cur- rent good manufacturing practice for finished pharmaceuti- cals [2012-04-01]. http ://www.accessdata.fda.gov/scripts/ cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=211.
  • 8McDowall RD. Unites States Pharmacopeia USP(37). Chap- ter <1058> :Analytical Instrument Qualification [Z]. USA, 2014.
  • 9PA/PH/OMCL (08)73 2R-OMCL. Guideline on Qualifi- cation of Equipment-Core Document Elaborated by the European Network Official Medicines Control Laborato ries [EB/OL]. http://www.edqm.eu/medias/fichiers/UPDAT- ED_Qu-alification_of_Equipment_core document.pdf.
  • 10Chan CC ,Lam H ,Lee YC. Analytical Method Validation and Instrument Performance Verification [M]. 2nd ed. Hoboken : Wiley Interscuence, 2004 : 751-869.

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部